Navigation Links
Predictive Biomarker Discovery for Oncology Small-Molecules and Biologics - a Webinar Hosted by Xtalks
Date:5/9/2013

Toronto, Canada (PRWEB) May 09, 2013

Recent advances in next-generation sequencing technologies are revolutionizing the way human disease is defined, providing avenues to develop novel, individualized therapies that target the genomic underpinnings of a patient’s condition. No disease has been more directly impacted by this than cancer, which is fundamentally a disorder of acquired somatic alterations.

Dr. Jameel Shah, Principal Scientist and Group Leader of Oncology at Eurofins Panlabs will speak about the Integration of High-Content Cell Line Profiling and Univariate Genomics Analysis to Discover and Prioritize Predictive Biomarkers in Oncology. Several examples will be discussed in this webinar to illustrate the predictive power of this approach to identify biomarkers of response.

Co-speaker DR. Jonathan Crane, Senior Scientist of Oncology and Cell Biology at Eurofins Panlabs will discuss High-content Live-cell Imaging Analysis of Therapeutic Monoclonal Antibody Binding and Potency Across 240 Genomically Defined Cancer Cell Lines. This presentation will describe the high-throughput parallelization of quantitative, comparative therapeutic antibody binding measurements and drug response profiling data by new high-content imaging.

A Q&A with the audience will follow the main presentation.

For more information about this event or to register, visit:
http://www.xtalks.com/OncoPanel-cell-line-profiling-and-imaging-analysis.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10704346.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Elsevier/Gold Standard Exclusive Publisher of New Predictive Drug Price Type
2. Data mining opens the door to predictive neuroscience
3. Eaton Apothecary Selects Predictive Acquisition Cost (PAC) Drug Price Type
4. GNS Healthcare Joins Orion Bionetworks to Develop Predictive Models for Multiple Sclerosis and Other Diseases
5. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
6. Biomarkers - Technologies, Markets and Companies
7. Use Biomarkers in Alzheimers Disease Clinical Trials, Says Expert Group
8. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
9. bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation
10. MarketsandMarkets: Global Biomarkers Market worth $25.79 Billion by 2016
11. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)...  Sequenom, Inc. (NASDAQ: SQNM ), a ... the development of innovative products and services, announced today ... States denied its petition to review decisions ... U.S. Patent No. 6,258,540 (",540 Patent") are not patent ... Supreme Court,s Mayo Collaborative Services v. Prometheus Laboratories decision.  ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, ... faculty of the University of North Carolina Kenan-Flagler Business School effective ... at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
Breaking Biology Technology:
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):